San Diego, California (February 15, 2016)—Creato Performance Solutions (www.creato.com) announced today that it has reached an agreement in principle with three corporations to implement the COMPASS® Quality Management System:
- DATAMARK, El Paso
- HRHCare, New York
- Sport & Spine Clinics, Washington DC
This new group of licensees reflects a high degree of diversity in the client base for Creato and COMPASS. Among the licensees is one of the largest Federally Qualified Health Centers in New York, a chiropractic clinic network in the nation’s capital, and a BPO firm, DATAMARK, with international presence.
DATAMARK is a leading provider of outsourced business services, including mail center management, data entry, document processing, and bilingual customer contact center services for Fortune 500 companies, government agencies and other large enterprises. “We see great potential in the COMPASS system to serve as a Business Process Management System for DATAMARK,” noted Ceasar Casas, Vice President of Global Operations for DATAMARK. “We look forward to working with this system to automate BPMS while supporting our Lean and Six Sigma projects across the company.”
The COMPASS Quality Management System was introduced to help organizations to identify, launch, track and complete improvement projects. Designed originally for manufacturing and expanded later into the healthcare industry, it is in place today in over 150 separate organizations.
About Creato: Creato Performance Solutions (www.creato.com) has been providing technologies and training to support corporate performance improvement for nearly 20 years. Today, Creato is a leading provider of Lean and Six Sigma deployment, and Project Portfolio Management products including the COMPASS® Quality Management System. Their combined classroom and online training programs are available through the American Society for Quality (ASQ), and a variety of other channel partners across the U.S. A recent study of 150 projects completed by Creato clients over the past 10 years revealed an average return on investment of 7:1.
# # #